Half of whooping cough cases in Australia are in adults.
It’s easy to think of whooping cough (also called pertussis) as a disease that only affects children and babies. But whooping cough in adults is more common than you might think.
Half of whooping cough cases in Australia are in adults.
It’s easy to think of whooping cough (also called pertussis) as a disease that only affects children and babies. But whooping cough in adults is more common than you might think.
In 2016, over 20,000 Australians caught whooping cough and over 8,499 of these people were adults.
Adults aged 20 years or older accounted for more than half of all the whooping cough cases reported in Australia between 2011 and 2016.
Whooping cough is a highly contagious disease, spreading to 90% of susceptible household contacts.
Whooping cough epidemics occur every 3 to 4 years.
Although serious and life-threatening to babies, whooping cough can also cause serious health complications in adults. One of the most common symptoms of whooping cough is the persistent or “100 day cough”.
When left untreated or undiagnosed symptoms of whooping cough can continue to worsen and manifest in the following:
• fits of rapid coughs followed by a high-pitched ‘whoop’ sound
• vomiting during or after coughing fits
• exhaustion after coughing fits
Many Australians have been vaccinated as a child, infant and adolescent. However, vaccinations received in childhood do not provide adequate protection against the disease in adult years. This is because immunity after vaccination diminishes over time, therefore leaving people at a greater risk of catching the disease.
If you are unsure if you are up to date with your vaccinations, speak to your healthcare professional.
The Australian Immunisation Handbook recommends vaccination for “any adult who wishes to reduce the likelihood of becoming ill with pertussis.”
SPANZ.ADAC.17.12.0287(1) - Date of preparation July 2018
Show All
By clicking on this link, you will be leaving this Sanofi hosted website, and depending on the link, will be redirected to either another Sanofi website (for example, to view the Sanofi Privacy Policy) or an independent third party website which is typically not a Sanofi controlled website and may not be located in Australia (“Third Party Website”).
Use of and access to any Third Party Site is subject to the terms, limitations and conditions set by the Third Party Site producer and applicable laws.
Sanofi does not generally develop or maintain Third Party Sites, nor does it necessarily control those sites availability or what information is contained on those sites in any given instance and makes no representation in relation to those sites to the maximum extent permitted under any applicable laws, regulations or codes.
Any information that you access via a Third Party Site, may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from Sanofi or via the Product Information.